Effect of Single Oral Doses of Lasmiditan When Coadministered With Single Oral Doses of Sumatriptan in Healthy Participants

NCT03076970 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: lasmiditan 200 mg
DRUG: Sumatriptan
DRUG: matching placebo

Sponsor

Eli Lilly and Company

Collaborators

[object Object]
[object Object]